Karla A. Temple

2.2k total citations
17 papers, 519 citations indexed

About

Karla A. Temple is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Karla A. Temple has authored 17 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Karla A. Temple's work include Sleep and related disorders (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Karla A. Temple is often cited by papers focused on Sleep and related disorders (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Karla A. Temple collaborates with scholars based in United States, Switzerland and United Kingdom. Karla A. Temple's co-authors include Matthew Brady, Dianne Deplewski, Ronald Cohen, Christine Yu, Kathleen R. Markan, Fredric E. Wondisford, Anne M. Smith, Kelly A. Kaihara, Xiao Zhou and Michael W. Roe and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and American Journal of Clinical Nutrition.

In The Last Decade

Karla A. Temple

15 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karla A. Temple United States 10 300 176 79 64 60 17 519
Ryan Faucette United States 8 305 1.0× 234 1.3× 64 0.8× 38 0.6× 53 0.9× 16 679
Beate Enigk Germany 14 256 0.9× 182 1.0× 127 1.6× 81 1.3× 69 1.1× 15 556
Beverley Balkau France 11 271 0.9× 155 0.9× 194 2.5× 79 1.2× 144 2.4× 15 695
Tomader Ali United States 11 206 0.7× 171 1.0× 51 0.6× 72 1.1× 70 1.2× 17 534
Candice Y. Li United States 5 341 1.1× 174 1.0× 61 0.8× 64 1.0× 147 2.5× 6 544
Anna Rune Sweden 6 509 1.7× 320 1.8× 112 1.4× 85 1.3× 104 1.7× 6 728
Milana Kokosar Sweden 8 225 0.8× 108 0.6× 80 1.0× 50 0.8× 32 0.5× 9 582
Soo-Hyun Park South Korea 12 278 0.9× 189 1.1× 28 0.4× 83 1.3× 73 1.2× 20 570
Dawn S. Sherman United States 7 333 1.1× 392 2.2× 56 0.7× 52 0.8× 54 0.9× 7 714
Verena Benz Germany 10 201 0.7× 146 0.8× 43 0.5× 143 2.2× 57 0.9× 13 496

Countries citing papers authored by Karla A. Temple

Since Specialization
Citations

This map shows the geographic impact of Karla A. Temple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla A. Temple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla A. Temple more than expected).

Fields of papers citing papers by Karla A. Temple

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karla A. Temple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla A. Temple. The network helps show where Karla A. Temple may publish in the future.

Co-authorship network of co-authors of Karla A. Temple

This figure shows the co-authorship network connecting the top 25 collaborators of Karla A. Temple. A scholar is included among the top collaborators of Karla A. Temple based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karla A. Temple. Karla A. Temple is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tjaden, Ashley H., Sharon L. Edelstein, Jill Reedy, et al.. (2025). The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the diabetes prevention program outcomes study. American Journal of Clinical Nutrition. 122(3). 715–723.
2.
Allaire, Benjamin T., Ashley H. Tjaden, Elizabeth M. Venditti, et al.. (2020). Diet quality, weight loss, and diabetes incidence in the Diabetes Prevention Program (DPP). BMC Nutrition. 6(1). 74–74. 18 indexed citations
3.
Craft, Suzanne, Amy Claxton, Mark Tripputi, et al.. (2019). 1561-P: Associations between ß-Cell Function and Cognitive Measures Differ in Youth vs. Adults with Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes (T2D). Diabetes. 68(Supplement_1). 1 indexed citations
4.
Temple, Karla A., Ashley H. Tjaden, Karen M. Atkinson, et al.. (2019). 1832-P: Impact of Habitual Daily Activity on Glucose Tolerance (GT) and ß-Cell Function in Adults with Impaired GT (IGT) or Type 2 Diabetes (T2D). Diabetes. 68(Supplement_1). 1 indexed citations
5.
Mokhlesi, Babak, Karla A. Temple, Ashley H. Tjaden, et al.. (2019). The association of sleep disturbances with glycemia and obesity in youth at risk for or with recently diagnosed type 2 diabetes. Pediatric Diabetes. 20(8). 1056–1063. 12 indexed citations
6.
Morselli, Lisa L., Karla A. Temple, Rachel Leproult, et al.. (2018). Determinants of Slow-Wave Activity in Overweight and Obese Adults: Roles of Sex, Obstructive Sleep Apnea and Testosterone Levels. Frontiers in Endocrinology. 9. 377–377. 13 indexed citations
7.
Temple, Karla A., Rachel Leproult, Lisa L. Morselli, et al.. (2018). Sex Differences in the Impact of Obstructive Sleep Apnea on Glucose Metabolism. Frontiers in Endocrinology. 9. 376–376. 15 indexed citations
8.
Mokhlesi, Babak, Karla A. Temple, Ashley N. Hogan, et al.. (2018). Self-Reported Sleep and Circadian Measures Are Not Associated with Glycemia in Adults with Prediabetes or Early Untreated Type 2 Diabetes (T2D). Diabetes. 67(Supplement_1).
9.
Milewski, Wieslawa, Karla A. Temple, Robin L. Wesselschmidt, & Manami Hara. (2008). Generation of embryonic stem cells from mouse insulin I promoter-green fluorescent protein transgenic mice and characterization in a teratoma model. In Vitro Cellular & Developmental Biology - Animal. 45(1-2). 1–5. 5 indexed citations
10.
Sinkevicius, Kerstin W., Joanna E. Burdette, Sylvia C. Hewitt, et al.. (2008). An Estrogen Receptor-α Knock-In Mutation Provides Evidence of Ligand-Independent Signaling and Allows Modulation of Ligand-Induced Pathways in Vivo. Endocrinology. 149(6). 2970–2979. 61 indexed citations
11.
Temple, Karla A., et al.. (2007). Uncoupling of 3T3‐L1 gene expression from lipid accumulation during adipogenesis. FEBS Letters. 581(3). 469–474. 8 indexed citations
12.
Temple, Karla A., et al.. (2007). Differential Modulation of 3T3-L1 Adipogenesis Mediated by 11β-Hydroxysteroid Dehydrogenase-1 Levels. Journal of Biological Chemistry. 282(15). 11038–11046. 25 indexed citations
13.
Yu, Christine, Kathleen R. Markan, Karla A. Temple, et al.. (2005). The Nuclear Receptor Corepressors NCoR and SMRT Decrease Peroxisome Proliferator-activated Receptor γ Transcriptional Activity and Repress 3T3-L1 Adipogenesis. Journal of Biological Chemistry. 280(14). 13600–13605. 187 indexed citations
14.
Temple, Karla A., et al.. (2004). An Intact DNA-binding Domain Is Not Required for Peroxisome Proliferator-activated Receptor γ (PPARγ) Binding and Activation on Some PPAR Response Elements. Journal of Biological Chemistry. 280(5). 3529–3540. 24 indexed citations
15.
Zhou, Xiao, Nobuyuki Shibusawa, Karla A. Temple, et al.. (2004). Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein. Nature Medicine. 10(6). 633–637. 116 indexed citations
16.
Temple, Karla A., Anne M. Smith, & David B. Cockram. (2000). Selenate-supplemented nutritional formula increases plasma selenium in hemodialysis patients. Journal of Renal Nutrition. 10(1). 16–23. 24 indexed citations
17.
Smith, Anne M. & Karla A. Temple. (1997). Selenium metabolism and renal disease. Journal of Renal Nutrition. 7(2). 69–72. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan Faucette Breakdown of academic impact, for papers by Beate Enigk Breakdown of academic impact, for papers by Beverley Balkau Breakdown of academic impact, for papers by Tomader Ali Breakdown of academic impact, for papers by Candice Y. Li Breakdown of academic impact, for papers by Anna Rune Breakdown of academic impact, for papers by Milana Kokosar Breakdown of academic impact, for papers by Soo-Hyun Park Breakdown of academic impact, for papers by Dawn S. Sherman Breakdown of academic impact, for papers by Verena Benz
Rankless by CCL
2026